GE HealthCare Technologies' market position, rising earnings, and improving financials make it an attractive investment opportunity. Read more on GEHC stock.

With few treatments available to treat Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

We all forget things. Names, dates, phone chargers – even why we walked into the kitchen. It’s called being human… or, let’s be honest, being over 40 in a digital world with too many tabs open in our ...

Dr. Ausim Azizi is among those seeing the overall early results, as Yale New Haven Hospital is in the forefront of research ...

Leqembi is the first FDA-approved drug shown to slow the progression of early-stage Alzheimer’s. Medi-Cal can cover Leqembi ...

Illimis Therapeutics’ Series B round was led by Korean venture capital firm DSC Investment. Seoul-based Illimis Therapeutics ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the drug discovery research for lecanemab (product name Leqembi®), an antibody indicated for early Alzheimer's ...

The Bioindustry Award, now marking its 9th year, recognizes achievements that have significantly contributed to the development of the bioindustry or are expected to contribute to its future growth.